The Foundation for Opioid Response Efforts is providing the website, pharmacybridge.org, which provides information about state regulations pertaining to pharmacist prescribing and administration of buprenorphine in interactive maps. Specifically, the website focuses on two innovative, pharmacy-based models for low-barrier buprenorphine induction and maintenance: collaborative care through a collaborative practice agreement and independent pharmacist prescribing. The information is based on the Pharmacists and Buprenorphine: Analysis of State Laws and Regulations October 2025 report, written by the Legislative Analysis and Public Policy Association, in collaboration with the University of Rhode Island College of Pharmacy.